Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 4
1993 5
1994 3
1995 2
1996 6
1997 4
1998 3
1999 14
2000 14
2001 20
2002 19
2003 31
2004 24
2005 39
2006 66
2007 47
2008 57
2009 55
2010 51
2011 72
2012 89
2013 103
2014 90
2015 87
2016 86
2017 101
2018 121
2019 127
2020 138
2021 136
2022 122
2023 99
2024 54

Text availability

Article attribute

Article type

Publication date

Search Results

1,675 results

Results by year

Filters applied: . Clear all
Page 1
Miltefosine.
[No authors listed] [No authors listed] 2017 Mar 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Mar 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643403 Free Books & Documents. Review.
Miltefosine is an orally available, alkyl phospholipid that is used in the treatment of both cutaneous and visceral leishmaniasis. Miltefosine therapy is often accompanied by transient mild-to-moderate serum aminotransferase elevations during the first 1 or 2 weeks …
Miltefosine is an orally available, alkyl phospholipid that is used in the treatment of both cutaneous and visceral leishmaniasis. …
Miltefosine Treatment of Cutaneous Leishmaniasis.
Soto JA, Berman JD. Soto JA, et al. Clin Infect Dis. 2021 Oct 5;73(7):e2463-e2464. doi: 10.1093/cid/ciaa1461. Clin Infect Dis. 2021. PMID: 33128373 No abstract available.
An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis.
Palić S, Beijnen JH, Dorlo TPC. Palić S, et al. Int J Antimicrob Agents. 2022 Jan;59(1):106459. doi: 10.1016/j.ijantimicag.2021.106459. Epub 2021 Oct 23. Int J Antimicrob Agents. 2022. PMID: 34695563 Review.
Miltefosine is an alkylphosphocholine agent with a broad spectrum of antiparasitic properties. ...The last extensive review of the pharmacology of miltefosine was published in 2012. Additional data on the clinical pharmacokinetics (PK) and pharmacodynamics (PD) of …
Miltefosine is an alkylphosphocholine agent with a broad spectrum of antiparasitic properties. ...The last extensive review of the ph …
No evidence for cardiotoxicity of miltefosine.
Dorlo TPC. Dorlo TPC. An Bras Dermatol. 2022 Jul-Aug;97(4):548-549. doi: 10.1016/j.abd.2022.03.002. Epub 2022 May 30. An Bras Dermatol. 2022. PMID: 35654652 Free PMC article. No abstract available.
Naegleria fowleri infections.
Linam WM, Cope JR. Linam WM, et al. Travel Med Infect Dis. 2017 Nov-Dec;20:65. doi: 10.1016/j.tmaid.2017.05.007. Epub 2017 May 10. Travel Med Infect Dis. 2017. PMID: 28501613 Free PMC article. No abstract available.
Miltefosine: A Miracle Drug for Meningoencephalitis Caused by Free-Living Amoebas.
Alli A, Ortiz JF, Morillo Cox Á, Armas M, Orellana VA. Alli A, et al. Cureus. 2021 Mar 4;13(3):e13698. doi: 10.7759/cureus.13698. Cureus. 2021. PMID: 33833918 Free PMC article. Review.
Until today, there are no definitive guidelines to be followed when treating such patients. However, miltefosine has demonstrated promising results. Miltefosine decreases the usual mortality rate in the three infections; however, there are few reports due to the low …
Until today, there are no definitive guidelines to be followed when treating such patients. However, miltefosine has demonstrated pro …
Miltefosine to treat leishmaniasis.
Berman J. Berman J. Expert Opin Pharmacother. 2005 Jul;6(8):1381-8. doi: 10.1517/14656566.6.8.1381. Expert Opin Pharmacother. 2005. PMID: 16013987 Review.
Miltefosine is a lecithin analogue and its mechanism may be to inhibit phosphatidylcholine biosynthesis in the causative parasites. The clinical half-life of miltefosine is approximately 7 days. Whether or not miltefosine can be used for widespread out-patien …
Miltefosine is a lecithin analogue and its mechanism may be to inhibit phosphatidylcholine biosynthesis in the causative parasites. T …
Miltefosine and cutaneous leishmaniasis.
Machado PR, Penna G. Machado PR, et al. Curr Opin Infect Dis. 2012 Apr;25(2):141-4. doi: 10.1097/QCO.0b013e3283509cac. Curr Opin Infect Dis. 2012. PMID: 22248979 Review.
RECENT FINDINGS: Miltefosine is being tested with small clinical trials mainly in endemic cutaneous leishmaniasis regions of South America and Iran. Severe cutaneous leishmaniasis forms successfully treated with miltefosine are reported. SUMMARY: The use of milte …
RECENT FINDINGS: Miltefosine is being tested with small clinical trials mainly in endemic cutaneous leishmaniasis regions of South Am …
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.
Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ. Dorlo TP, et al. J Antimicrob Chemother. 2012 Nov;67(11):2576-97. doi: 10.1093/jac/dks275. Epub 2012 Jul 24. J Antimicrob Chemother. 2012. PMID: 22833634 Review.
Miltefosine is an alkylphosphocholine drug with demonstrated activity against various parasite species and cancer cells as well as some pathogenic bacteria and fungi. ...We here review the most salient pre-clinical and clinical pharmacological aspects of miltefosine …
Miltefosine is an alkylphosphocholine drug with demonstrated activity against various parasite species and cancer cells as well as so …
Miltefosine to Treat Childhood Cutaneous Leishmaniasis.
Barba PJ, Morgado-Carrasco D, Quera A. Barba PJ, et al. Actas Dermosifiliogr. 2022 Sep;113(8):827-831. doi: 10.1016/j.ad.2020.11.033. Epub 2021 Dec 17. Actas Dermosifiliogr. 2022. PMID: 36031197 Free article. English, Spanish. No abstract available.
1,675 results